scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1101105789 |
P356 | DOI | 10.1007/S11060-018-2803-Y |
P698 | PubMed publication ID | 29460097 |
P50 | author | Adomas Bunevicius | Q43239704 |
P2093 | author name string | Giorgio Iervasi | |
Robertas Bunevicius | |||
Arimantas Tamasauskas | |||
Sarunas Tamasauskas | |||
Vytenis Deltuva | |||
Andrius Radziunas | |||
Edwards R Laws | |||
P2860 | cites work | Secretion of interleukin-6 by human meningioma cells: possible autocrine inhibitory regulation of neoplastic cell growth | Q72121877 |
Effect of interleukin-1 and dexamethasone on interleukin-6 production and growth in human meningiomas | Q74295906 | ||
CRP, IL-6 and endothelin-1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early graft occlusion and late cardiovascular events? | Q79399756 | ||
Peritumoral edema and prognosis in intracranial meningioma surgery | Q31152316 | ||
Independent association of extent of resection with survival in patients with malignant brain astrocytoma | Q33375165 | ||
Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth | Q33674790 | ||
Assessment of outcome after severe brain damage | Q34216702 | ||
Serum hsCRP: A Novel Marker for Prediction of Cerebrovascular Accidents (Stroke). | Q35046289 | ||
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis | Q35182277 | ||
Association of C-reactive protein with cognitive impairment | Q35591752 | ||
Impaired survival and long-term neurological problems in benign meningioma | Q35914505 | ||
Role of IL-6 in the invasiveness and prognosis of glioma | Q35958905 | ||
Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis | Q36134214 | ||
Peripheral Inflammatory Markers and Antioxidant Response during the Post-Acute and Chronic Phase after Severe Traumatic Brain Injury | Q37385572 | ||
The pro- and anti-inflammatory properties of the cytokine interleukin-6. | Q37836084 | ||
Pathophysiological mechanisms regulated by cytokines in gliomas | Q38280199 | ||
Resection of olfactory groove meningioma - a review of complications and prognostic factors. | Q38547145 | ||
Immune microenvironment of gliomas | Q38712457 | ||
Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation | Q38930939 | ||
Peritumoral edema on MRI at initial diagnosis: an independent prognostic factor for glioblastoma? | Q39976588 | ||
Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme | Q40344057 | ||
Clinical prognostic factors in adults with astrocytoma: Historic cohort | Q40743051 | ||
Early Dynamics of P-selectin and Interleukin 6 Predicts Outcomes in Ischemic Stroke | Q40861162 | ||
Association of pre-operative depressive and anxiety symptoms with five-year survival of glioma and meningioma patients: a prospective cohort study | Q41340729 | ||
Interleukin-6 gene amplification and shortened survival in glioblastoma patients. | Q42549981 | ||
Prognostic value of erythrocyte sedimentation rate and C-reactive protein in the blood of patients with glioma | Q43715694 | ||
Increased C-reactive protein implies a poorer stage-specific prognosis in colon cancer | Q43897776 | ||
Elevated serum IL-17A but not IL-6 in glioma versus meningioma and schwannoma | Q44573064 | ||
Influence of interleukin-6 on the development of peritumoral brain edema in meningiomas | Q47792323 | ||
Low triiodothyronine syndrome as a predictor of poor outcomes in patients undergoing brain tumor surgery: a pilot study: clinical article | Q48130916 | ||
Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma | Q48137961 | ||
Role of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and inteleukin-6 in predicting a poor outcome after a stroke | Q48181059 | ||
APRIL is increased in serum of patients with brain glioblastoma multiforme. | Q48246760 | ||
Th1/Th2 cytokine imbalance in meningioma, anaplastic astrocytoma and glioblastoma multiforme patients. | Q48548524 | ||
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013. | Q52096226 | ||
Prognostic importance of markers for inflammation, angiogenesis and apoptosis in high grade glial tumors during temozolomide and radiotherapy. | Q53265090 | ||
Similar immunity profiles in patients with meningioma and glioma tumors despite differences in the apoptosis and necrosis of circulating lymphocyte and monocyte populations. | Q55461101 | ||
The acute phase response | Q71618259 | ||
P577 | publication date | 2018-02-19 | |
P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
P1476 | title | Prognostic role of high sensitivity C-reactive protein and interleukin-6 in glioma and meningioma patients |